Skip to content

Comparison of spinal Ropivacaine(0.75%) heavy and Bupivacine(0.5%) heavy in perineal surgeries

A comparative evaluation of spinal hyperbaric Ropivacaine(0.75%) and hyperbaric Bupivacaine(0.5%) in elective perineal surgeries-A prospective randomised trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050723
Enrollment
54
Registered
2023-03-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: HYPERBARIC BUPIVACAINE(0.5%): Under strict asepsis with patient in sitting position Lumbar Puncture (LP) will be done at L3 L4 intervertebral space using 25 G Quinkes spinal needle. Fre

Sponsors

JSSAHER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age 18-60 years 2.Either sex 3.ASA Status I & II

Exclusion criteria

Exclusion criteria: 1.Patient refusal 2.Bleeding disorder 3.Spine deformities 4.Acute cardiovascular and respiratory disease 5.Allergy to local anaesthesia 6.Psychiatric illness 7.BMI >30

Design outcomes

Primary

MeasureTime frame
Comparative evaluation of Hyperbaric Ropivacaine (0.5%) and Hyperbaric Bupivacaine (0.75%) in elective spinal anaesthesia in perineal surgeries in terms of onset, maximum level and duration of sensory and motor block.Timepoint: from the time of administration of drug,5 min 10 min 20 min 30 min 40 min 50 min 60 min

Secondary

MeasureTime frame
1.Incidence of hypotension and bradycardia after administration of Hyperbaric Ropivacaine and Hyperbaric Bupivacaine. 2.Any incidence of transient neurological symptoms after administration of Hyperbaric Ropivacaine and Hyperbaric Bupivacaine. Timepoint: From the time of administration of drug 5 min 10 min 20 min 30 min 40 min 50 min 60 min

Countries

India

Contacts

Public ContactRaghavendra babu t

JSS medical college

raghavendrababut@jssuni.edu.in9591107777

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026